FENC

$10.35-3.27%visit website

FENNEC PHARMACEUTICALS INC.

Market Cap

$363M

Live price × SEC shares (Aug 11, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.27

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

6.1

TTM to Jun 2026 · revenue

P/B

8.6

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	12,462	13,777	15,108	17,874	59,221
Research & development	29	20	49	118	216
Total operating expenses	12,651	16,331	15,227	16,137	60,346
Operating income	(189)	(2,554)	(119)	1,737	(1,125)
Interest expense	586	308	7	3	904
Pretax income				2,015
Income tax				42.0
Net income	(638)	(4,787)	201	1,973	(3,251)
EPS (basic) ($)	(0.02)		0.01	0.06	(0.12)
EPS (diluted) ($)	(0.02)		0.01	0.05	(0.12)
Weighted avg. shares (basic)	27,889		34,336	34,545
Weighted avg. shares (diluted)	27,889		35,548	36,430

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

16 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 17, 2026 accepted 4:03 PM ET	8.01Other events	Document SEC ↗
Jun 10, 2026 accepted 5:19 PM ET	5.07Shareholder vote	Document SEC ↗
May 22, 2026 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
May 18, 2026 accepted 5:12 PM ET	5.02Officer / director change	Document SEC ↗
Apr 28, 2026 accepted 4:46 PM ET	5.02Officer / director change	Document SEC ↗
Apr 22, 2026 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
Apr 7, 2026 accepted 4:27 PM ET	8.01Other events	Document SEC ↗
Mar 24, 2026 accepted 4:22 PM ET	2.02Earnings release	Document SEC ↗
Mar 16, 2026 accepted 5:21 PM ET	8.01Other events	Document SEC ↗
Mar 4, 2026 accepted 4:23 PM ET	8.01Other events	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

40%

W/W -11.3pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

8.94x

Avg Daily Selling (90d)

1,251 sh/day

Baseline Daily Selling

369 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-15	2026-09-16	Brughera Marco Maria	Director	Sale	15.5K	$10.29	$160K	0	View
2026-09-01	2026-09-01	Raykov Rosty	Former Director	Sale	10.0K	$12.11	$121K	124.4K	View
2026-08-31	2026-08-31	Sayad Pierre Sargis	Chief Medical Officer	Sale	12.0K	$12.18	$146K	9,519	View
2026-08-27	2026-08-28	Andrade Robert	CHIEF FINANCIAL OFFICER	Sale	75.0K	$11.78	$884K	217.7K	View
2026-07-01	2026-07-02	Raykov Rosty	Former Director	Sale	9,599	$10.41	$100K	138.9K	View

1–5 of 20

1 / 4

Recent News

Fennec Pharmaceuticals (FENC) executive acquires 168 award shares, not through a market purchase.

Stock Titan · 2026-11-02

Award shares bring Fennec Pharmaceuticals (FENC) CEO’s direct holding to 70,844 shares.

Stock Titan · 2026-11-02

FENC: Fennec Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas

Stocktwits · 2026-10-15

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

Yahoo Finance · 2026-09-17

Fennec Pharmaceuticals (NasdaqCM:FENC) Stock Forecast & Analyst Predictions

Simply Wall St · 2026-09-09

Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views

Yahoo Finance · 2026-08-14

Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade)

Seeking Alpha · 2026-08-12

Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ...

Yahoo Finance · 2026-08-11

Fennec Pharmaceuticals surges 8% as Q2 earnings and revenue beat estimates

Yahoo Finance · 2026-08-11

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Yahoo Finance · 2026-08-11

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Yahoo Finance · 2026-08-05

FENC Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Yahoo Finance · 2026-06-22

Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting

Yahoo Finance · 2026-05-22

Fennec Pharmaceuticals Inc. Q1 2026 Earnings Call Summary

Yahoo Finance · 2026-05-14

Informational purposes only, not investment advice.

FENC

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

FENNEC PHARMACEUTICALS INC. (FENC)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-09-15	Brughera Marco Maria	S	15,545	$159,958.05
2026-09-01	Raykov Rosty	S	10,000	$121,100
2026-08-31	Sayad Pierre Sargis	S	12,000	$146,160
2026-08-27	Andrade Robert	S	75,000	$883,500
2026-07-01	Raykov Rosty	S	9,599	$99,925.59